Evidence map›Paper›PMID 38731472›Full record

ArticleMolecules (Basel, Switzerland)2024

Protection of Si Nanowires against A

Xuechun Zhao, Chenye Mou, Jiayi Xu, Wei Cui, Yijing Shi, Yangzhe Wang, Tian Luo, Wei Guo, Jichun Ye, Wanghua Chen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xuechun ZhaoSchool of Physical Science and Technology, Ningbo University, Ningbo 315211, China.
Chenye MouZhejiang Provincial Key Laboratory of Pathophysiology, Health Science Center, Ningbo University, Ningbo 315211, China.
Jiayi XuZhejiang Provincial Key Laboratory of Pathophysiology, Health Science Center, Ningbo University, Ningbo 315211, China.
Wei CuiZhejiang Provincial Key Laboratory of Pathophysiology, Health Science Center, Ningbo University, Ningbo 315211, China.
Yijing ShiSchool of Physical Science and Technology, Ningbo University, Ningbo 315211, China.
Yangzhe WangSchool of Physical Science and Technology, Ningbo University, Ningbo 315211, China.
Tian LuoNingbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo 315201, China.
Wei GuoNingbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo 315201, China.
Jichun YeNingbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences, Ningbo 315201, China.ORCID 0000-0002-3901-7155
Wanghua ChenSchool of Physical Science and Technology, Ningbo University, Ningbo 315211, China.ORCID 0000-0001-6167-3178

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disease characterized by the accumulation of amyloid beta (A

Indexed as

Amyloid beta-PeptidesNanowiresNeuroprotective AgentsSiliconAlzheimer DiseaseAnimalsCell SurvivalPC12 CellsPeptide FragmentsProtein AggregatesRatsAmyloid beta-Peptidesamyloid beta-protein (1-42)Neuroprotective AgentsPeptide FragmentsProtein AggregatesSiliconAlzheimer’s diseaseamyloid βPC12 cellssilicon nanowirestoxicity

Identifiers

PMID38731472
PMCPMC11085270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.